Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Prime Medicine, Inc. (PRME) had Normalized Income after Taxes of $-42.44M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.15M |
|
$-42.11M |
|
-- |
|
$1.15M |
|
$44.44M |
|
$-43.28M |
|
$1.18M |
|
$-42.11M |
|
$-42.44M |
|
$-42.11M |
|
$-42.11M |
|
$-42.11M |
|
|
Normalized Income after Taxes |
$-42.44M |
$-43.28M |
|
$-41.81M |
|
177.22M |
|
177.22M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$96.80M |
|
$17.08M |
|
$152.24M |
|
$249.04M |
|
$31.69M |
|
-- |
|
$177.54M |
|
$209.23M |
|
$39.81M |
|
$39.81M |
|
$39.81M |
|
180.74M |
|
| Cash Flow Statement Financials | |
$-83.76M |
|
$67.42M |
|
$0.75M |
|
$76.72M |
|
$61.14M |
|
$-15.58M |
|
$9.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3750.87% |
|
-3750.87% |
|
-- |
|
-3648.96% |
|
-3648.96% |
|
$-84.02M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-105.78% |
|
-105.78% |
|
-16.91% |
|
-105.78% |
|
$0.22 |
|
$-0.47 |
|
$-0.47 |
|